11FS | pdb_000011fs

Effector complex from type IV-C CRISPR-Cas system

• PDB DOI: https://doi.org/10.2210/pdb11FS/pdb
• NAKB: 11FS
• EM Map EMD-75667: EMDB EMDataResource

• Classification: RNA BINDING PROTEIN
• Organism(s): Pyrococcus abyssi
• Expression System: Escherichia coli
• Mutation(s): No 


• Deposited: 2026-02-21 Released: 2026-08-26 
• Deposition Author(s): Pittman, C., Xu, C., Catchpole, R., Garrett, S., Fuchs, R., Makarova, K., Koonin, E., Zhao, P., Wells, L., Graveley, B., Ke, A., Terns, M.
• Funding Organization(s): National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)

---

Experimental Data Snapshot

• Method: ELECTRON MICROSCOPY
• Resolution: 3.20 Å
• Aggregation State: PARTICLE 
• Reconstruction Method: SINGLE PARTICLE 

Literature

Type IV-C CRISPR-Cas effector complexes recognize double-stranded DNA and switch on collateral cleavage of ssDNA and RNA.

Pittman, C.C., Xu, C., Catchpole, R.J., Garrett, S., Fuchs, R., Chu, X., Makarova, K.S., Koonin, E.V., Zhao, P., Wells, L., Graveley, B.R., Ke, A., Terns, M.P.

(2026) Cell Rep 45: 117939-117939

• PubMed: 42700392 
• DOI: https://doi.org/10.1016/j.celrep.2026.117939
• Primary Citation Related Structures: 
  11FS, 11HC, 11HD


• PubMed Abstract: 
  

  Type IV-C CRISPR-Cas systems remain enigmatic compared to other class 1 systems. Here, we expand the type IV-C catalog, identifying two phylogenetically distinct clades primarily found in archaea (IV-C1) or bacteria (IV-C2), distinguishable by the Cas10IVc subunit architecture. We functionally and structurally characterize type IV-C1 systems from Thermococcus onnurineus (Ton) and Pyrococcus abyssi (Pab). Type IV-C complexes assemble with crRNAs derived from distinct CRISPR arrays and recognize a 5'-GGG-3' protospacer adjacent motif (PAM) to bind double-stranded DNA targets. Target recognition activates the HD domain of Cas10IVc, triggering metal-dependent collateral cleavage of single-stranded DNA and RNA. This behavior is explained by allosteric alignment of the HD active site, triggered by PAM-dependent R-loop formation, as revealed by cryo-EM. Together, our findings suggest that type IV-C systems provide immunity via non-specific cleavage of nucleic acids generated during mobile genetic element replication or transcription.

---

Organizational Affiliation: 
• Department of Microbiology, University of Georgia, Athens, GA 30605, USA.
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA.
Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30605, USA.
Department of Genetics and Genome Sciences, University of Connecticut, Farmington, CT 06030, USA.
RNA Division, New England Biolabs, Ipswich, MA 01938, USA.
Computational Biology Branch, Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA. Electronic address: [e-mail].
Department of Microbiology, University of Georgia, Athens, GA 30605, USA; Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30605, USA; Department of Genetics, University of Georgia, Athens, GA 30605, USA. Electronic address: [e-mail].

Biological Assembly 1  

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Hetero 15-mer - A7B6C1D1 

Local Symmetry: Helical - H  (Explore in 3D)
Local Stoichiometry: Homo 7-mer - A7 Local Symmetry: Helical - H  (Explore in 3D)
Local Stoichiometry: Hetero 12-mer - A6B6 

Biological assembly 1 assigned by authors.

Biological Assembly Evidence: electron microscopy

Macromolecule Content 

• Total Structure Weight: 478.62 kDa 
• Atom Count: 30,547 
• Modeled Residue Count: 3,694 
• Deposited Residue Count: 4,072 
• Unique protein chains: 4
• Unique nucleic acid chains: 3

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Cas10IVc	A	608	Pyrococcus abyssi	Mutation(s): 0

Entity ID: 2
Molecule	Chains	Sequence Length	Organism	Details	Image
Cas7c	B [auth C], G [auth H], H [auth I], I [auth J], J [auth K], K [auth L], L [auth M]	330	Pyrococcus abyssi	Mutation(s): 0

Entity ID: 3
Molecule	Chains	Sequence Length	Organism	Details	Image
Cas5c	C [auth D]	306	Pyrococcus abyssi	Mutation(s): 0

Entity ID: 7
Molecule	Chains	Sequence Length	Organism	Details	Image
Cas11c	M [auth N], N [auth O], O [auth P], P [auth Q], Q [auth R], R [auth S]	124	Pyrococcus abyssi	Mutation(s): 0

Entity ID: 4
Molecule	Chains	Length	Organism	Image
Non-Target Strand DNA	D [auth E]	10	Pyrococcus abyssi

Entity ID: 5
Molecule	Chains	Length	Organism	Image
Target Strand DNA	E [auth F]	47	Pyrococcus abyssi

Entity ID: 6
Molecule	Chains	Length	Organism	Image
crRNA (47-MER)	F [auth G]	47	Pyrococcus abyssi

Small Molecules

Ligands 2 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
ZN	U [auth A]	ZINC ION Zn PTFCDOFLOPIGGS-UHFFFAOYSA-N
MG (Subject of Investigation/LOI)	S [auth A], T [auth A]	MAGNESIUM ION Mg JLVVSXFLKOJNIY-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

• Method: ELECTRON MICROSCOPY
• Resolution: 3.20 Å
• Aggregation State: PARTICLE 
• Reconstruction Method: SINGLE PARTICLE 

EM Software:

Task	Software Package	Version
MODEL REFINEMENT	PHENIX	1.21.2_5419
RECONSTRUCTION	cryoSPARC

Structure Validation

Entry History 

& Funding Information

Deposition Data

• Released Date: 2026-08-26 
Deposition Author(s): Pittman, C., Xu, C., Catchpole, R., Garrett, S., Fuchs, R., Makarova, K., Koonin, E., Zhao, P., Wells, L., Graveley, B., Ke, A., Terns, M.

---

Funding Organization	Location	Grant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)	United States	R35118174

Revision History  

• Version 1.0: 2026-08-26
  Type: Initial release
  
• Version 1.1: 2026-09-16
  Changes: Data collection, Database references